Submitted by Anonymous (not verified) on 18 November 2025 - 12:15
Human medicines European public assessment report (EPAR): Enwylma, denosumab, Date of authorisation: 26/06/2025, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Enwylma, denosumab, Date of authorisation: 26/06/2025, Status: Authorised